Article Text

Download PDFPDF
Review
Impact of gender identity in the inflammatory bowel disease population: an evidence review and practical steps for gastroenterologists
  1. Michael Colwill1,2,
  2. Richard Pollok1,2,
  3. Leighton Seal2,3,
  4. Andrew Poullis1,2
  1. 1St George's University of London, London, London, UK
  2. 2St George's University Hospitals NHS Foundation Trust, London, UK
  3. 3Tavistock and Portman NHS Foundation Trust, London, London, UK
  1. Correspondence to Dr Michael Colwill, Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, UK; m2307534{at}sgul.ac.uk

Abstract

There has been greater societal awareness of differences in gender identity and sexual orientation in recent years. The rates of identifying as transgender or gender non-conforming (TGNC) are increasing and are known to be higher in the younger population and will therefore be over-represented in the inflammatory bowel disease (IBD) subpopulation. However, despite this there is very little in the literature with regards to those who identify as TGNC and are diagnosed with IBD (TGNC-IBD). Many TGNC individuals have poor experiences when seeking healthcare and many physicians find it a challenging and daunting clinical situation to be faced with. We reviewed the available literature with regards to TGNC-IBD population demographics, physical, mental and sexual health considerations, medication interactions and implications for surgery in this heterogenous group. We have identified areas that need further research and suggested simple and practical steps that can be adopted in order to help healthcare providers improve the experience for TGNC individuals diagnosed with IBD and the quality of care they provide.

  • IBD
  • ULCERATIVE COLITIS
  • CROHN'S DISEASE

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors AP and MC were involved in the conception. MC was responsible for the initial drafting. All authors were involved in reviewing and finalising the article. The authors have all made contributions to the writing of the manuscript. All authors have read and agreed upon the submitted version of this paper and bear responsibility for the content.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.